Reported value
$9.6B
2026 Q2 filing
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 4.67% | 2,392,000 | ADDED (+4.1%) |
| PRAX | Praxis Precision Medicines, Inc. | 3.36% | 963,351 | HELD |
| VTRS | Viatris Inc | 3.35% | 20,206,170 | HELD |
| CNC | CENTENE CORP | 3.28% | 4,901,000 | TRIMMED (-17.2%) |
| UTHR | UNITED THERAPEUTICS Corp | 2.58% | 457,000 | HELD |
| LEGN | LEGEND BIOTECH CORP-ADR | 2.45% | 8,137,638 | ADDED (+5.9%) |
| COGT | COGENT BIOSCIENCES INC | 2.02% | 5,006,104 | TRIMMED (-44.6%) |
| GMAB | GENMAB A/S | 1.97% | 6,865,000 | ADDED (+178.8%) |
| BKD | Brookdale Senior Living Inc. | 1.95% | 11,637,032 | HELD |
| VERA | VERA THERAPEUTICS INC | 1.75% | 3,916,400 | ADDED (+5.2%) |
| IONS | IONIS PHARMACEUTICALS INC | 1.64% | 1,979,669 | HELD |
| CELC | Celcuity Inc. | 1.58% | 1,451,014 | TRIMMED (-15.3%) |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1.57% | 15,096,403 | ADDED (+0.4%) |
| NAMS | NewAmsterdam Pharma Co N.V. | 1.51% | 4,264,789 | HELD |
| ACHC | Acadia Healthcare Company, Inc. | 1.39% | 4,520,000 | HELD |
| TNGX | TANGO THERAPEUTICS INC | 1.37% | 4,190,611 | ADDED (+1.1%) |
| AHCO | AdaptHealth Corp. | 1.25% | 11,477,730 | HELD |
| PHVS | Pharvaris N.V. | 1.22% | 3,376,042 | ADDED (+8.0%) |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 1.18% | 1,389,055 | TRIMMED (-11.7%) |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 1.14% | 1,125,313 | ADDED (+10.3%) |
| LRMR | LARIMAR THERAPEUTICS INC | 1.13% | 35,606,974 | HELD |
| MLYS | MINERALYS THERAPEUTICS INC | 1.11% | 3,958,000 | NEW |
| IDYA | IDEAYA BIOSCIENCES INC | 1.06% | 2,714,503 | ADDED (+77.4%) |
| XENE | XENON PHARMACEUTICALS INC | 1.02% | 1,615,696 | HELD |
| SVRA | SAVARA INC | 0.87% | 13,569,000 | HELD |
| LNTH | Lantheus Holdings, Inc. | 0.87% | 752,999 | TRIMMED (-9.1%) |
| SNDX | Syndax Pharmaceuticals Inc | 0.86% | 3,779,900 | HELD |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 0.80% | 1,332,836 | ADDED (+56.5%) |
| PFE | PFIZER INC | 0.76% | 3,040,000 | HELD |
| INDV | Indivior Pharmaceuticals, Inc. | 0.71% | 1,648,895 | TRIMMED (-46.8%) |
| BIO | BIO-RAD LABORATORIES, INC. | 0.69% | 226,070 | HELD |
| SPRY | ARS Pharmaceuticals, Inc. | 0.63% | 7,503,812 | HELD |
| STOK | STOKE THERAPEUTICS INC | 0.62% | 1,823,500 | HELD |
| GPCR | STRUCTURE THERAPEUTICS INC | 0.61% | 1,086,000 | ADDED (+41.4%) |
| NVST | Envista Holdings Corp | 0.61% | 2,210,100 | HELD |
| INSP | Inspire Medical Systems, Inc. | 0.60% | 1,296,862 | TRIMMED (-52.0%) |
| CDNA | CareDx, Inc. | 0.59% | 1,997,618 | TRIMMED (-8.8%) |
| BSX | BOSTON SCIENTIFIC CORP | 0.59% | 1,315,000 | NEW |
| BLTE | BELITE BIO, INC | 0.57% | 357,199 | ADDED (+17.5%) |
| PBLS | PARABILIS MEDICINES INC | 0.54% | 1,880,704 | NEW |
| CERT | Certara, Inc. | 0.51% | 7,512,928 | TRIMMED (-3.8%) |
| IRON | DISC MEDICINE INC | 0.50% | 657,000 | HELD |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 0.39% | 4,885,446 | HELD |
| TYRA | TYRA BIOSCIENCES INC | 0.34% | 1,017,000 | ADDED (+85.2%) |
| MNPR | MONOPAR THERAPEUTICS INC | 0.31% | 323,745 | HELD |
| SION | Sionna Therapeutics, Inc. | 0.31% | 680,916 | TRIMMED (-29.8%) |
| AVLN | AVALYN PHARMA INC | 0.25% | 731,000 | NEW |
| FHTX | FOGHORN THERAPEUTICS INC | 0.22% | 4,394,367 | HELD |
| BBNX | Beta Bionics, Inc. | 0.22% | 1,324,000 | HELD |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 0.21% | 67,935 | HELD |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 0.21% | 283,000 | HELD |
| ODTX | ODYSSEY THERAPEUTICS INC | 0.20% | 1,046,139 | NEW |
| STLN | STARLING ONCOLOGY INC | 0.19% | 3,360,052 | HELD |
| KYTX | KYVERNA THERAPEUTICS INC | 0.19% | 2,000,000 | HELD |
| ALMR | ALAMAR BIOSCIENCES INC | 0.17% | 600,000 | NEW |
| CHE | CHEMED CORP | 0.15% | 30,000 | NEW |
| SGP | SPYGLASS PHARMA INC | 0.13% | 550,000 | HELD |
| ADAG | ADAGENE INC-ADR | 0.12% | 2,666,666 | NEW |
| COAG | HEMAB THERAPEUTICS HOLDINGS | 0.11% | 275,000 | NEW |
| MOBI | MOBIA MEDICAL INC | 0.09% | 670,752 | NEW |
| EMBC | Embecta Corp. | 0.09% | 2,534,961 | HELD |
| VCYT | VERACYTE INC | 0.06% | 101,000 | TRIMMED (-86.1%) |
| ANNX | Annexon, Inc. | 0.03% | 583,913 | HELD |
| ALEC | ALECTOR INC | 0.02% | 1,055,192 | HELD |
| EW | Edwards Lifesciences Corp | 0.01% | 13,702 | HELD |
| MIRM | Mirum Pharmaceuticals, Inc. | 0.01% | 6,027 | NEW |
| HUM | HUMANA INC | <0.01% | 917 | HELD |
| STLNW | ONCOLOGY INSTITUTE INC CW-22 | <0.01% | 1,250,000 | HELD |
| PMVP | PMV Pharmaceuticals, Inc. | <0.01% | 8,790 | HELD |
The weights above sum to 61.5% of the fund’s reported 13F value. Only positions matched to a U.S.-listed ticker are listed; the remainder sits in unmatched or non-equity positions in the filing.
Exited this quarter: CGEM, CMPX, KYMR, MANE, MYGN, NBIX, QSI, TSHA.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 14, 2026. CIK 0001009258. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only.
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.